Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Views
    • Webinars
    • PharmSci360
  • Pharma 50
    • 2026 Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertisers
    • Advertise
    • PR Submissions
    • Eblast Submissions
  • SUBSCRIBE

Smart Pills Could Revolutionize Prevention, Diagnosis of Gut Diseases

By RMIT University | April 24, 2017

Phase one human trials of smart pills that could revolutionise the prevention and diagnosis of gut disorders and diseases have been completed by researchers in Melbourne, Australia. Source: RMIT University

Researchers at RMIT University in Melbourne, Australia, have successfully completed phase one human trials of ingestible capsules that have the potential to revolutionise the prevention and diagnosis of gut disorders and diseases.

The research team, led by the pills’ co-inventor Distinguished Professor Kourosh Kalantar-zadeh, tested the ingestible smart capsules (the size of a vitamin pill) that journey through and measure gas levels in the gastrointestinal tract.

One in five people will suffer from a gastrointestinal disorder in their lifetime, with 30 per cent of patients remaining undiagnosed. RMIT is one of the leading universities in the world researching the development of ingestible sensors.

The ingestible technology has demonstrated several thousand -times more sensitivity to gut gases than alternative techniques.

“Currently, one of the only methods for diagnosing gut disorders, such as mal-absorption of carbohydrates, irritable bowel syndrome and inflammable bowel disease, is to measure hydrogen concentrations in the breath,” Kalantar-zadeh said.

“However, breath tests are mired by a lack of sensitivity and specificity and are unable to provide the necessary gold standard for diagnosis.”

Co-inventor Dr Kyle Berean said: “Ingestible sensors also offer a reliable diagnostic tool for colon cancer, meaning that people won’t have to undergo colonoscopies in future.”

A key finding from the initial trials was just how safe the new technology is.

“Smart pills are harmless and there is no risk of capsule retention,” Berean said.

An added advantage is that the capsules can be synched with smartphones, meaning results are easily accessible by users and doctors online.

The potential applications from this technology are profound.

“The sensors allow us to measure all the fluids and gases in the gut giving us a multidimensional picture of the human body,” Kalantar-zadeh said. “Gas sensing is just the beginning.”

The human trials were undertaken with colleagues from Monash University, who Kalantar-zadeh was quick to praise.

“We have been lucky to have Monash medical academics helping us on this journey,” he said. “Without their input we would not be able to proceed.”


Filed Under: Drug Discovery

 

Related Articles Read More >

Insilico’s AI-designed TEAD inhibitor shrank tumors in 4 of 22 mesothelioma patients; randomized Phase 2a planned for 2027
If Trump gets Europe to pay more for drugs, more new medicines could follow — eventually
Antibody - visual concept of immune System - 3D illustration
Fresenius picks the biosimilars, WuXi Biologics builds them in a deal covering up to 37 candidates
Physician in a white coat reviewing information on a tablet with a patient in an exam room.
What real-world data shows about current cancer care
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Drug Delivery Business News
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Pharmaceutical Processing World
  • R&D World
  • Subscribe to our E-Newsletter
  • About Us
  • Contact Us

Copyright © 2026 Arrowfly LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Views
    • Webinars
    • PharmSci360
  • Pharma 50
    • 2026 Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertisers
    • Advertise
    • PR Submissions
    • Eblast Submissions
  • SUBSCRIBE